Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Free Cash Flow
|
Adaptive Biotechnologies Corp
Free Cash Flow Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Free Cash Flow
-$144.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Free Cash Flow
$6.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Free Cash Flow
$5.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Free Cash Flow
$903m
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Free Cash Flow
$1.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Free Cash Flow
$1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
See Also
What is Adaptive Biotechnologies Corp's Free Cash Flow?
Free Cash Flow
-144.8m
USD
-144.8m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Free Cash Flow amounts to -144.8m USD.
What is Adaptive Biotechnologies Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
11%
11%
Over the last year, the Free Cash Flow growth was 26%. The average annual Free Cash Flow growth rates for Adaptive Biotechnologies Corp have been 11% over the past three years .
You don't have any saved screeners yet
